US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

296.31

+0.55000.19%

Pre-market: 288.70-7.6100-2.57%08:01 EDT

Volume:260.53K

Turnover:75.10M

Market Cap:570.24M

PE:- -

High:300.34

Open:290.97

Low:281.50

Close:295.76

52wk High:341.93

52wk Low:71.88

Shares:1.92M

Float Shares:1.92M

Volume Ratio:0.69

T/O Rate:13.54%

Dividend:1.01

Dividend Rate:0.34%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Sector Update: Healthcare

MT Newswires Live

Codexis to Participate in Cantor Global Healthcare Conference 2026

SL Science Files FDA Drug Master File for GDT Cell-Derived Exosomes

MT Newswires Live

Harmony Biosciences to Participate in 2026 Cantor Global Healthcare Conference

Pluri Announces Pricing of $3.3 Million Registered Direct Offering and Concurrent Private Placement with a Single Healthcare Focused Institutional Investor

Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference

Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Immuneering (IMRX)

Hygeia Healthcare Lifts Profit, Boosts Cash Flow and Unveils Expanded Shareholder Return Plan

Analysts Have Conflicting Sentiments on These Healthcare Companies: NeoGenomics (NEO) and Medtronic (MDT)

Hygeia Healthcare to Present 2026 Interim Results via Investor Call

IHH Healthcare's Attributable Profit Jumps 29% in Q2

MT Newswires Live

Jazz Pharmaceuticals (JAZZ) Stock May Be Undervalued As FDA Cancer Approval Lands

Simply Wall St.

Revolution Medicines: Buy Rating Reiterated as FDA Approval and Strong Prelaunch Demand Support Unchanged $225 Price Target

Health Care Roundup: Market Talk

FDA Grants First Broad RAS Inhibitor Approval for Advanced Pancreatic Cancer, Cutting Mortality by 60% in Second-Line Setting

Huadong Medicine's Lymphoma Drug Gets US FDA's Fast Track Designation

MT Newswires Live

Fujian Unveils Plans to Boost Cross-Strait Biotech and Medical Collaboration Zone

CSPC Innovation Pharma's Colorectal Cancer Drug Gets US FDA's Fast Track Designation; Shares Up 4%

MT Newswires Live

IHH Healthcare's 2QFY2026 patmi up 29% y-o-y

The Edge Singapore

Nicox Gets 2027 FDA Decision Date for Glaucoma Drug NCX 470

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/LABU/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":296.31,"timestamp":1788206400000,"preClose":295.76,"halted":0,"volume":260525,"hourTrading":{"tag":"盘前","latestPrice":288.7,"preClose":296.31,"latestTime":"08:01 EDT","volume":1697,"amount":492969.33619999996,"timestamp":1788264118695,"change":-7.61,"changeRate":-0.025683,"amplitude":0.030354},"delay":0,"changeRate":0.0018596159047877042,"floatShares":1924486,"shares":1924486,"eps":0,"marketStatus":"Pre-Mkt","change":0.55,"latestTime":"09-01 08:10:03 EDT","open":290.97,"high":300.34,"low":281.5,"amount":75101085.83125001,"amplitude":0.0637,"askPrice":290,"askSize":200,"bidPrice":285.97,"bidSize":200,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788269400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":296.31,"sharesOutstanding":3074486,"nav":295.545,"aum":568772231.45,"dividendRate":0.0034,"bidAskSpread":0.002847,"preHourTrading":{"tag":"盘前","latestPrice":288.7,"preClose":296.31,"latestTime":"08:01 EDT","volume":1697,"amount":492969.33619999996,"timestamp":1788264118695,"change":-7.61,"changeRate":-0.025683,"amplitude":0.030354},"postHourTrading":{"tag":"盘后","latestPrice":295.02,"preClose":296.31,"latestTime":"19:59 EDT","volume":2518,"amount":745089.4272,"timestamp":1788220773434,"change":-1.29,"changeRate":-0.004354,"amplitude":0.010268},"volumeRatio":0.6867414366828442,"impliedVol":0.9253,"impliedVolPercentile":0.5777},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1924486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.6867414366828442,"shares":1924486,"dividePrice":1.0075,"high":300.34,"amplitude":0.0637,"preClose":295.76,"low":281.5,"week52Low":71.88,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":296.31,"eps":0,"divideRate":0.0034,"volume":260525,"delay":0,"ttmEps":0,"open":290.97,"prevYearClose":159.39,"prevWeekClose":295.76,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":308.33,"twentyDayClose":228.04,"sixtyDayClose":179.22},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662007177","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2662007177","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662007177?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:01","pubTimestamp":1787835662,"startTime":"0","endTime":"0","summary":"Healthcare stocks were declining pre-bell Thursday, with the State Street Health Care Select Sector SPDR ETF  0.7% lower and the iShares Biotechnology ETF  down 0.5%.Novo Nordisk  said China's National Medical Products Administration has accepted its marketing application for the oral version of its weight-loss drug Wegovy, Reuters reported. Novo Nordisk stock was down more than 2% premarket.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XLV","IBB","NVOX","LU0154236417.USD","NVO","LU1093756168.USD","IE00BZ1G4Q59.USD","BK4599","LU1093756325.SGD","IE00BKVL7J92.USD","BK4532","BK4007","BK4581","THNR","XBI","LABU","BK4585","BK4588","NVOC","PPH","OZEM","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662851820","title":"Codexis to Participate in Cantor Global Healthcare Conference 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662851820","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662851820?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:00","pubTimestamp":1787835600,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif., Aug.  27, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/27/3352067/24825/en/codexis-to-participate-in-cantor-global-healthcare-conference-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","XBI","HCSG","BK4585","XLV","LABU","BK4121","BK4581","BK4137","CDXS","LU0029874061.USD","BK4588","EES"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662755707","title":"SL Science Files FDA Drug Master File for GDT Cell-Derived Exosomes","url":"https://stock-news.laohu8.com/highlight/detail?id=2662755707","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662755707?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:41","pubTimestamp":1787834466,"startTime":"0","endTime":"0","summary":"SL Science  said Thursday that its licensor, JY BioMed, filed a new drug master file with the US Food and Drug Administration covering exosomes derived from Gamma Delta T, or GDT, cells.The company said the filing, numbered 044612, adds manufacturing and quality documentation for the cell-free exosome format of the GDT technology, potentially streamlining regulatory work for future programs.SL Science said the exosomes could have potential applications in oncology, including brain cancer, as preclinical research suggests they can trigger tumor cell death, stimulate immune responses and cross the blood-brain barrier.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SLBT","GDT","BK4585","LABU","BK4588","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662856680","title":"Harmony Biosciences to Participate in 2026 Cantor Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2662856680","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662856680?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:05","pubTimestamp":1787832300,"startTime":"0","endTime":"0","summary":"PLYMOUTH MEETING, Pa., Aug.  27, 2026 (GLOBE NEWSWIRE) -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will participate in a fireside chat at the 2","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/27/3351980/0/en/harmony-biosciences-to-participate-in-2026-cantor-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","HCSG","LABU","BK4588","BK4137","BK4585","XBI","LU0128526141.USD","BK4581","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662859610","title":"Pluri Announces Pricing of $3.3 Million Registered Direct Offering and Concurrent Private Placement with a Single Healthcare Focused Institutional Investor","url":"https://stock-news.laohu8.com/highlight/detail?id=2662859610","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662859610?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:00","pubTimestamp":1787832000,"startTime":"0","endTime":"0","summary":"HAIFA, Israel, Aug.  27, 2026 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri”), a biotechnology company, leveraging its proprietary three-dimensional (\"3D\") cell expansion platform","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/27/3351959/11974/en/pluri-announces-pricing-of-3-3-million-registered-direct-offering-and-concurrent-private-placement-with-a-single-healthcare-focused-institutional-investor.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","XLV","BK4137","XBI","BK4588","CDMO","LU0029874061.USD","BK4585","BK4581","BK4139","HCSG","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662163701","title":"Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2662163701","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662163701?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:50","pubTimestamp":1787827800,"startTime":"0","endTime":"0","summary":"DEER PARK, Ill., Aug.  27, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/27/3351865/0/en/eton-pharmaceuticals-to-participate-at-2026-wells-fargo-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0162691827.USD","LU0683600562.USD","LU1069347547.HKD","LU2361045086.USD","BK4207","LU1267930227.SGD","LU0128526141.USD","LU0310799852.SGD","LU0310800379.SGD","LU0211328371.USD","LU0708994859.HKD","XBI","BK4137","LU1074936037.SGD","LU2461242641.AUD","LU0029864427.USD","IYF","LU1280957306.USD","LU0742534661.SGD","LU0128525929.USD","LABU","PGF","LU0289960550.SGD","LU0130517989.USD","LU0971096721.USD","FTXO","BK4582","LU0106831901.USD","LU0251131958.USD","LU0256863811.USD","LU0417517546.SGD","LU1894683264.USD","KBWB","BK4585","LU1894683348.USD","LU0029874061.USD","TFNS","XLV","LU0175139822.USD","LU1035773651.USD","BK4559","LU2361044949.HKD","LU0787776722.HKD","HCSG","LU0267386448.USD","LU0868494708.USD","LU1814569148.SGD","IE00B19Z3581.USD","LU0072461881.USD","LU0149725797.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662706801","title":"Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Immuneering (IMRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662706801","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662706801?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:30","pubTimestamp":1787826622,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Revolution Medicines (RVMD) and Immuneering (IMRX) w...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-and-immuneering-imrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-and-immuneering-imrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","XBI","CANC","BBH","BK4137","PTH","LU0128526141.USD","IE00B4R5TH58.HKD","LABU","IE0009354923.USD","RVMD","XLV","BK4139","IE00BFTCPJ56.SGD","HCSG","IE0002141913.USD","IE0009355771.USD","LU0029874061.USD","IE00BJJMRZ35.SGD","BK4563","LU0109394709.USD","IE00B2B36J28.USD","IDNA","IMRX","IE00BJT1NW94.SGD","BK4581","LU0320765992.SGD","LU0889565916.HKD","BK4539","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662703205","title":"Hygeia Healthcare Lifts Profit, Boosts Cash Flow and Unveils Expanded Shareholder Return Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2662703205","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662703205?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:10","pubTimestamp":1787825420,"startTime":"0","endTime":"0","summary":"An announcement from Hygeia Healthcare Holdings Co., Ltd. ( ($HK:6078) ) is now available. Hygeia Healthcare reported interim revenue of RMB1,961.0...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hygeia-healthcare-lifts-profit-boosts-cash-flow-and-unveils-expanded-shareholder-return-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hygeia-healthcare-lifts-profit-boosts-cash-flow-and-unveils-expanded-shareholder-return-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4581","XLV","HCSG","LU0128526141.USD","LU0029874061.USD","BK4585","BK4137","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662703720","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: NeoGenomics (NEO) and Medtronic (MDT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662703720","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662703720?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:10","pubTimestamp":1787825408,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on NeoGenomics (NEO) and Medtronic (MDT). NeoGenomics...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-neogenomics-neo-and-medtronic-mdt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-neogenomics-neo-and-medtronic-mdt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","LU1116320737.USD","LU1244550577.SGD","IE00BQXX3F31.USD","IE00BVYPNW00.USD","LU0162691827.USD","IE000M9KFDE8.USD","LU0012050646.USD","XBI","BK4566","LU0265550359.USD","LU2089283258.USD","LU0158827781.USD","BK4581","IE00BGHQF631.EUR","LU0029874061.USD","LU0211331839.USD","BK4196","IE00B3PB1722.GBP","LU0006306889.USD","NEO","HCSG","IE00B42XCP33.USD","LU0072461881.USD","LU1116320901.HKD","LU1244550494.USD","LU0211326839.USD","LU1989764748.USD","FBT","LU2028103732.USD","LU0208291251.USD","BK4137","BK4585","MDT","LU2089984988.USD","LU0432979614.USD","LU2023251221.USD","LU0128526141.USD","LU1989771016.USD","LU1291159041.SGD","IE00BFXG1179.USD","LU0496365809.HKD","XLV","LU1571399168.USD","LU0106261372.USD","LU1983299246.USD","IE00BVYPNV92.GBP","LU1506573853.SGD","LU1989764664.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662213703","title":"Hygeia Healthcare to Present 2026 Interim Results via Investor Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2662213703","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662213703?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:09","pubTimestamp":1787825368,"startTime":"0","endTime":"0","summary":"Hygeia Healthcare Holdings Co., Ltd. ( ($HK:6078) ) just unveiled an update. Hygeia Healthcare Holdings Co., Ltd. has announced it will host a conf...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hygeia-healthcare-to-present-2026-interim-results-via-investor-call?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hygeia-healthcare-to-present-2026-interim-results-via-investor-call?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0128526141.USD","HCSG","XBI","BK4581","BK4137","LABU","BK4588","XLV","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662770481","title":"IHH Healthcare's Attributable Profit Jumps 29% in Q2","url":"https://stock-news.laohu8.com/highlight/detail?id=2662770481","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662770481?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:46","pubTimestamp":1787824019,"startTime":"0","endTime":"0","summary":"IHH Healthcare's  attributable profit to owners jumped 29% during the second quarter of the year to 573 million ringgit from 443 million ringgit a year earlier, according to a Thursday filing with the Malaysian Exchange.Earnings per share came in at 0.0648 ringgit compared with 0.0502 ringgit in the year-ago period.Revenue rose 12% year over year to 7.05 billion ringgit from 6.3 billion ringgit.The healthcare services provider declared an interim dividend of 0.055 ringgit per share for the period, payable by Oct. 30.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0128526141.USD","XBI","HCSG","BK4585","XLV","BK6511","LABU","BK4581","Q0F.SI","BK4588","BK4137","LU0029874061.USD","BK6092"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662703987","title":"Jazz Pharmaceuticals (JAZZ) Stock May Be Undervalued As FDA Cancer Approval Lands","url":"https://stock-news.laohu8.com/highlight/detail?id=2662703987","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662703987?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:22","pubTimestamp":1787822560,"startTime":"0","endTime":"0","summary":"Jazz Pharmaceuticals has doubled in the past year, yet the valuation checks send a more muted signal, with the stock screening as undervalued on earnings multiples but only showing a mixed overall value score. For investors, the question now is whether the recent rally has already captured much of the good news around the company.\n\nOver the past 12 months, Jazz Pharmaceuticals has delivered a return of about 100%, which puts the recent share price near the upper end of its one year range and...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-jazz/jazz-pharmaceuticals/news/jazz-pharmaceuticals-jazz-stock-may-be-undervalued-as-fda-ca","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-jazz/jazz-pharmaceuticals/news/jazz-pharmaceuticals-jazz-stock-may-be-undervalued-as-fda-ca","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VGFPF","IE00BN0W2W23.USD","LU0320765992.SGD","FEBU","DECU","PMDE","IE00BN0W2V16.EUR","BK4533","LU0154245673.USD","BK4585","BK4532","JAZZ","IE00BN0W2T93.GBP","LU0154245756.USD","LU0109394709.USD","JOYT","LABU","LU0889565916.HKD","BK4007","VOTE","RGLO","GXDW","LU0823416689.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662745297","title":"Revolution Medicines: Buy Rating Reiterated as FDA Approval and Strong Prelaunch Demand Support Unchanged $225 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2662745297","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662745297?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:35","pubTimestamp":1787819736,"startTime":"0","endTime":"0","summary":"Bank of America Securities analyst Alec Stranahan has maintained their bullish stance on RVMD stock, giving a Buy rating yesterday. Alec Stranahan ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/revolution-medicines-buy-rating-reiterated-as-fda-approval-and-strong-prelaunch-demand-support-unchanged-225-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/revolution-medicines-buy-rating-reiterated-as-fda-approval-and-strong-prelaunch-demand-support-unchanged-225-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","RVMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662771196","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2662771196","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662771196?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:20","pubTimestamp":1787818800,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0721 GMT - Novo Nordisk faces persistent concerns over the scope","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["D05.SI","LU0315178854.USD","LU0878005551.USD","BK6523","LU0326948709.USD","XBI","LU0823417737.USD","LU0011963245.USD","LU0886674414.USD","SG9999001903.USD","LU0165289439.USD","LU1634259391.SGD","SG9999004360.SGD","SG9999003826.SGD","BK6516","LU0588545490.SGD","LU0061477393.USD","LU2238330802.EUR","SG9999009443.AUD","SG9999000475.SGD","LU0762540952.USD","LU0823417653.USD","LU2152927971.USD","BK4588","LU0823413587.USD","LU0211331839.USD","BK6112","LU1211504680.USD","SG9999003800.SGD","SG9999000343.SGD","LU0210637038.USD","SG9999005177.SGD","LU1282649810.SGD","LU1497733631.SGD","SGXZ58947870.SGD","LU0543330483.HKD","LABU","LU0672654166.SGD","LU1282649067.USD","LU0648948544.HKD","XLV","LU0577902454.USD","LU0823413660.USD","LU0873338254.USD","SG9999008742.SGD","LU0955669360.SGD","SG9999004220.SGD","LU0577902538.SGD","LU0823038988.USD","LU0048597586.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164145033","title":"FDA Grants First Broad RAS Inhibitor Approval for Advanced Pancreatic Cancer, Cutting Mortality by 60% in Second-Line Setting","url":"https://stock-news.laohu8.com/highlight/detail?id=1164145033","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164145033?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:01","pubTimestamp":1787817666,"startTime":"0","endTime":"0","summary":"On August 26, the U.S. Food and Drug Administration (FDA) granted approval to Revolution Medicines for its oral therapy Rasonque (generic name: daraxonrasib), designated for adults with metastatic...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662779426","title":"Huadong Medicine's Lymphoma Drug Gets US FDA's Fast Track Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2662779426","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662779426?lang=en_us&edition=fundamental","pubTime":"2026-08-27 15:58","pubTimestamp":1787817488,"startTime":"0","endTime":"0","summary":"Huadong Medicine's  HDM2005 for injection obtained a fast track designation from the U.S. Food and Drug Administration, according to a Shenzhen bourse filing on Thursday.The drug is being developed as a treatment for patients with relapsed or refractory mantle cell lymphoma, who had at least two lines of systemic therapy, including a BTK inhibitor.The Chinese drugmaker's shares rose 1% at the close.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0132","BK0183","BK0196","BK4588","LU1969619763.USD","LU2328871848.SGD","BK0175","BK0209","000963","LABU","BK0187","BK0188","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158123171","title":"Fujian Unveils Plans to Boost Cross-Strait Biotech and Medical Collaboration Zone","url":"https://stock-news.laohu8.com/highlight/detail?id=1158123171","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158123171?lang=en_us&edition=fundamental","pubTime":"2026-08-27 15:00","pubTimestamp":1787814046,"startTime":"0","endTime":"0","summary":"On August 27, the \"15th Five-Year Plan for Health Development in Fujian Province\" was officially released, outlining key initiatives for the upcoming period.Among the highlighted measures, the plan...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","XLV","VHT","WDNA","BK4581","BK4585","BK4588","XBI","IXJ","BK4550","HELX","159760"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662483775","title":"CSPC Innovation Pharma's Colorectal Cancer Drug Gets US FDA's Fast Track Designation; Shares Up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662483775","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662483775?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:51","pubTimestamp":1787813504,"startTime":"0","endTime":"0","summary":"CSPC Innovation Pharmaceutical's  first-in-class PD-1/IL-15 bispecific fusion protein, SYS6090 , received a fast track designation from the U.S. Food and Drug Administration, according to a Wednesday disclosure on the Shenzhen bourse.The Chinese pharmaceutical company's shares rose 4% during Thursday's afternoon trade.The drug is developed by the company's subsidiary, CSPC Giant Biopharmaceutical, as a treatment for patients with microsatellite-stable or mismatch repair-proficient metastatic colorectal cancer.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0226","BK4588","BK4585","LABU","300765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662058303","title":"IHH Healthcare's 2QFY2026 patmi up 29% y-o-y","url":"https://stock-news.laohu8.com/highlight/detail?id=2662058303","media":"The Edge Singapore ","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662058303?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:34","pubTimestamp":1787812483,"startTime":"0","endTime":"0","summary":"\"We remain confident on reaching double-digit ROE by 2028,\" says group CEO Dr Prem Kumar Nair","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/news/results/ihh-healthcares-2qfy2026-patmi-29-y-o-y?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/news/results/ihh-healthcares-2qfy2026-patmi-29-y-o-y?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["BK6092","LABU","BK4588","Q0F.SI","XLV","BK6511","BK4581","XBI","HCSG","BK4585","LU0128526141.USD","LU0029874061.USD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662577328","title":"Nicox Gets 2027 FDA Decision Date for Glaucoma Drug NCX 470","url":"https://stock-news.laohu8.com/highlight/detail?id=2662577328","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662577328?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:18","pubTimestamp":1787811533,"startTime":"0","endTime":"0","summary":"An update from Nicox SA ( ($FR:ALCOX) ) is now available. Nicox SA said the U.S. Food and Drug Administration has accepted the New Drug Application...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nicox-gets-2027-fda-decision-date-for-glaucoma-drug-ncx-470?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nicox-gets-2027-fda-decision-date-for-glaucoma-drug-ncx-470?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":7,"totalSize":408,"code":"91000000","status":"200"}]}}